Jacobs Levy Equity Management, Inc Gossamer Bio, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,887,512 shares of GOSS stock, worth $1.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,887,512

Previous 1,444,617 30.66%

Holding current value

$1.62 Million

Previous $1.3 Million 43.69%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.79 - $1.25 $349,887 - $553,618	442,895 Added 30.66%	1,887,512 $1.87 Million
Q2 2024 Aug 14, 2024	SELL	$0.51 - $1.27 $96,628 - $240,623	-189,467 Reduced 11.59%	1,444,617 $1.3 Million
Q1 2024 May 15, 2024	SELL	$0.8 - $1.51 $375,171 - $708,135	-468,964 Reduced 22.3%	1,634,084 $1.93 Million
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $1.01 Million - $2.27 Million	2,103,048 New	2,103,048 $1.91 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $3.66 Million - $6.11 Million	-612,496 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $2.5 Million - $3.7 Million	-295,936 Reduced 32.58%	612,496 $5.32 Million
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $697,581 - $969,859	-68,931 Reduced 7.05%	908,432 $10.3 Million
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $211,091 - $385,204	-29,116 Reduced 2.89%	977,363 $12.3 Million
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $432,600 - $527,231	-54,075 Reduced 5.1%	1,006,479 $8.17 Million
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $3.7 Million - $4.7 Million	429,272 Added 68.0%	1,060,554 $9.81 Million
Q4 2020 Feb 16, 2021	SELL	$8.3 - $13.59 $125,587 - $205,630	-15,131 Reduced 2.34%	631,282 $6.1 Million
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $4.34 Million - $5.66 Million	383,635 Added 145.99%	646,413 $8.02 Million
Q2 2020 Aug 17, 2020	BUY	$9.52 - $15.98 $1.62 Million - $2.72 Million	170,045 Added 183.37%	262,778 $3.42 Million
Q1 2020 May 15, 2020	BUY	$8.0 - $15.48 $91,744 - $177,524	11,468 Added 14.11%	92,733 $941,000
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $1.2 Million - $2.18 Million	81,265 New	81,265 $1.27 Million

Others Institutions Holding GOSS

# of Institutions

108

Shares Held

167M

Call Options Held

430K

Put Options Held

519K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Gossamer Bio, Inc. Transaction History